AHA Cardiovascular Genome Phenome Study (CVGPS)



American Heart Association Cardiovascular Genome Phenome Study (CVGPS)

The Cardiovascular Genome Phenome Study (CVGPS) is a collaborative effort, spearheaded by the American Heart Association (AHA), to accelerate the future of cardiovascular medicine. CVGPS combines the power of long-term population studies with the precision of molecular analysis to unravel key distinctions between and within subgroups of patients. The discoveries it generates will point the way toward better-targeted, safer, and more effective treatments, based on a deeper understanding of patients’ characteristics, including e.g. risk profiles and therapeutic needs.

The CVGPS is a collaboration among AHA, Boston University (BU) and the University of Mississippi Medical Center (UMMC), the academic coordinating center homes, respectively, of the Framingham Heart Study (FHS) and the Jackson Heart Study (JHS). The Jackson Heart Study also involves Jackson State University (JSU) and Tougaloo College (TC) as partner institutions.

Through the rich diversity of constituent participant/patient populations, CVGPS research will bring inter-individual and patient-to-patient differences into ever sharper focus for common diseases such as atherosclerosis and hypertension.

CVGPS Award Terms and Conditions

Learn more about CVGPS

Introduction to CVGPS
Joseph Loscalzo, M.D., Ph.D., FAHA
Chair, CVGPS Science Oversight Committee
 
Boston University / Framingham Heart Study's (FHS) Role
Vasan Ramachandran, M.D.
 
The University of Mississippi / Jackson Heart Study's (JHS) Role
Adolfo Correa, M.D., Ph.D.
 
NHLBI and Its Role
Michael Lauer, M.D., FAHA
 
Announcement of CVGPS Pathway Grant Recipients
Steven R. Houser, Ph.D., FAHA
Chair, AHA Research Committee
 

CVGPS Publications

CVGPS research aims to improve common blood pressure medication
American Heart Association Blog | March 20, 2015

Obama details 'precision medicine' research initiative

American Heart Association Blog | Jan. 30, 2015

American Heart Association Cardiovascular Genome-Phenome Study: Foundational Basis and Program

Circulation | Nov. 19, 2014



View the Cardiovascular Genome Phenome Study Awardees



Funding Opportunities

CVGPS Pathway Grants

  • Funded at $250,000/year for 2 years for a total of $500,000

CVGPS Grand Challenge Awards

  • Funded at $500,000 for 4 years for a total of $2 million
  • Next Grand Challenge Awards will be offered in 2016

CVGPS Frequently Asked Questions